Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 410 for multiple

Edit search filters
  1. Instrument for Patient Capacity Assessment (ICAN) in Patients with Multiple Chronic Conditions

    Rochester, MN

  2. Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

    Jacksonville, FL

  3. A Multi-centered, Double-blind, Randomized, Placebo-controlled Study of TEV-56286 for the Treatment of Multiple System Atrophy

    Rochester, MN

  4. A Study Using a New Ultra-low Dose CT Scanner to Find Lung Nodules

    Rochester, MN

  5. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Rochester, MN

  6. A Study to Validate a Self-Report Measurement of Treatment Burden for People with Multiple Chronic Conditions

    Rochester, MN

  7. A Study to Evaluate Single vs. Multiple Dose Regimens of Privigen in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

    Rochester, MN

  8. Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

    Jacksonville, FL

  9. Dasatinib And Quercetin With CAR T Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  10. A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer